Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1756-9966
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Flubendazole demonstrates valid antitumor effects by inhibiting STAT3 and activating autophagy ; volume:38 ; number:1 ; day:8 ; month:7 ; year:2019 ; pages:1-13 ; date:12.2019
Journal of experimental & clinical cancer research ; 38, Heft 1 (8.7.2019), 1-13, 12.2019
- Urheber
-
Lin, Shichong
Yang, Lehe
Yao, Yulei
Xu, Lingyuan
Xiang, Youqun
Zhao, Haiyang
Wang, Liangxing
Zuo, Zhigui
Huang, Xiaoying
Zhao, Chengguang
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1186/s13046-019-1303-z
- URN
-
urn:nbn:de:101:1-2019110520492286525621
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:20 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Lin, Shichong
- Yang, Lehe
- Yao, Yulei
- Xu, Lingyuan
- Xiang, Youqun
- Zhao, Haiyang
- Wang, Liangxing
- Zuo, Zhigui
- Huang, Xiaoying
- Zhao, Chengguang
- SpringerLink (Online service)
Ähnliche Objekte (12)
ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling
Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model
Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma
CAA-derived IL-6 induced M2 macrophage polarization by activating STAT3
METTL3 promotes colorectal cancer progression through activating JAK1/STAT3 signaling pathway
E7080 (Lenvatinib), a Multi-Targeted Tyrosine Kinase Inhibitor, Demonstrates Antitumor Activities Against Colorectal Cancer Xenografts
Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma models
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer
IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis
From Valid Measurements to Valid Mini-Apps
Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice
Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile
ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling
Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model
Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma
CAA-derived IL-6 induced M2 macrophage polarization by activating STAT3
METTL3 promotes colorectal cancer progression through activating JAK1/STAT3 signaling pathway
E7080 (Lenvatinib), a Multi-Targeted Tyrosine Kinase Inhibitor, Demonstrates Antitumor Activities Against Colorectal Cancer Xenografts
Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma models
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer
IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis
From Valid Measurements to Valid Mini-Apps
Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice
Gentulizumab, a novel anti-CD47 antibody with potent antitumor activity and demonstrates a favorable safety profile
ARF6 promotes hepatocellular carcinoma proliferation through activating STAT3 signaling
Recombinant Newcastle disease virus expressing P53 demonstrates promising antitumor efficiency in hepatoma model
Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma
CAA-derived IL-6 induced M2 macrophage polarization by activating STAT3
METTL3 promotes colorectal cancer progression through activating JAK1/STAT3 signaling pathway
E7080 (Lenvatinib), a Multi-Targeted Tyrosine Kinase Inhibitor, Demonstrates Antitumor Activities Against Colorectal Cancer Xenografts
Targeted transcriptional downregulation of MYC using epigenomic controllers demonstrates antitumor activity in hepatocellular carcinoma models
Selinexor (KPT-330) demonstrates anti-tumor efficacy in preclinical models of triple-negative breast cancer
IL-17A induces osteoblast differentiation by activating JAK2/STAT3 in ankylosing spondylitis
From Valid Measurements to Valid Mini-Apps
Zinc protoporphyrin IX, a heme oxygenase-1 inhibitor, demonstrates potent antitumor effects but is unable to potentiate antitumor effects of chemotherapeutics in mice